Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-16
DOI
10.1007/s12325-022-02333-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants
- (2022) Huei-Kai Huang et al. ANNALS OF INTERNAL MEDICINE
- Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation
- (2022) Robert P Giugliano EUROPEAN HEART JOURNAL SUPPLEMENTS
- Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom
- (2022) Antonio González Pérez et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effectiveness and safety of oral anticoagulants in the treatment of acute venous thromboembolism: A nationwide comparative cohort study in France
- (2022) Laurent Bertoletti et al. THROMBOSIS AND HAEMOSTASIS
- Non-vitamin K antagonist oral anticoagulants in venous thromboembolism patients: a meta-analysis of real-world studies
- (2022) Zhi-Yan Liu et al. BMC Cardiovascular Disorders
- Thromboembolism in Older Adults
- (2021) Peter L. Gross et al. Frontiers in Medicine
- Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials
- (2021) Tingting Wu et al. JOURNAL OF NEUROLOGY
- Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY
- (2021) Alexander T. Cohen et al. ADVANCES IN THERAPY
- Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population
- (2021) Jeffrey S. Berger et al. CURRENT MEDICAL RESEARCH AND OPINION
- 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
- (2021) Jan Steffel et al. EUROPACE
- Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis
- (2021) Junguo Zhang et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism
- (2021) Faizan Khan et al. ANNALS OF INTERNAL MEDICINE
- Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation
- (2021) Dae Hyun Kim et al. ANNALS OF INTERNAL MEDICINE
- Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
- (2021) Joris Komen et al. HEART
- Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants
- (2021) Ofra Barnett-Griness et al. HEART
- Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: communication from the ISTH SSC Subcommittee on Control of Anticoagulation
- (2021) Matteo Candeloro et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation
- (2021) Karlyn A. Martin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study
- (2021) Samuel Z. Goldhaber et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population‐based cohort studies
- (2021) Hendrika A. Ham et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation
- (2021) Giovanni Luca Botto et al. Journal of Clinical Medicine
- Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
- (2021) Gregory Y. H. Lip et al. JAMA Network Open
- Impact of Age, Sex, and Renal Function on the Efficacy and Safety of Direct Oral Anticoagulants vs. Vitamin K Antagonists for the Treatment of Acute Venous Thromboembolism: A Meta-Analysis of 22,040 Patients
- (2021) Bo Zhou et al. Frontiers in Cardiovascular Medicine
- Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
- (2021) Margot K. Davis et al. JACC: CardioOncology
- Risk of Atrial Fibrillation According to Cancer Type
- (2021) Jun Pil Yun et al. JACC: CardioOncology
- Impact of frailty on all-cause mortality and major bleeding in patients with atrial fibrillation: A meta-analysis
- (2021) Lian He et al. AGEING RESEARCH REVIEWS
- Risk of Intracranial Hemorrhage Caused by Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation (from a Network Meta-Analysis of Randomized Controlled Trials)
- (2021) Meina Lv et al. AMERICAN JOURNAL OF CARDIOLOGY
- Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants
- (2021) Arnar B. Ingason et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and Safety of Direct Oral Anticoagulants in Patients with Diabetes and Nonvalvular Atrial Fibrillation: Meta-Analysis of Observational Studies
- (2021) Bo Cao et al. Cardiovascular Therapeutics
- 582: TRANEXAMIC ACID IN GASTROINTESTINAL BLEEDING
- (2021) Joanna Dionne et al. CRITICAL CARE MEDICINE
- Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?
- (2021) Dimitrios Giannis et al. European Journal of Internal Medicine
- The high-risk bleeding category of different scores in patients with venous thromboembolism: Systematic review and meta-analysis
- (2021) Miguel Marques Antunes et al. European Journal of Internal Medicine
- Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study
- (2021) X.L. Marston et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation
- (2021) Wayne A. Ray et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multi‐center retrospective study evaluating the efficacy and safety of apixaban versus warfarin for treatment of venous thromboembolism in patients with severe obesity
- (2021) Ashley Crouch et al. PHARMACOTHERAPY
- Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism
- (2020) Ghadeer K Dawwas et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- How I assess and manage the risk of bleeding in patients treated for venous thromboembolism
- (2020) Frederikus A. Klok et al. BLOOD
- Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
- (2020) Ole-Christian W Rutherford et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review
- (2020) Stefano Ballestri et al. ADVANCES IN THERAPY
- Non-Vitamin K Antagonist Oral Anticoagulant for Atrial Fibrillation in Obese Patients
- (2020) Stephen Y. Wang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Direct-acting oral anticoagulant use at extremes of body weight: Literature review and recommendations
- (2020) Kelly Covert et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice
- (2020) Michael Fralick et al. ANNALS OF INTERNAL MEDICINE
- Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data
- (2020) Olivia S. Costa et al. CURRENT MEDICAL RESEARCH AND OPINION
- Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis
- (2020) Natalie Tapaskar et al. DIGESTIVE DISEASES AND SCIENCES
- Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation
- (2020) Marina Serper et al. HEPATOLOGY
- Severe renal impairment and risk of bleeding during anticoagulation for venous thromboembolism
- (2020) Judith Catella et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study
- (2020) Steve Deitelzweig et al. Journal of Clinical Medicine
- Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs
- (2020) Daniela Poli et al. European Journal of Internal Medicine
- COVID-19, coagulopathy and venous thromboembolism: more questions than answers
- (2020) Marco Marietta et al. Internal and Emergency Medicine
- 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
- (2020) Gordon F. Tomaselli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE
- (2020) Henri Bounameaux et al. THROMBOSIS RESEARCH
- Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
- (2020) Ashley Chen et al. Journal of the American Heart Association
- Direct Oral Anticoagulant Use in Chronic Kidney Disease and Dialysis Patients With Venous Thromboembolism: A Systematic Review of Thrombosis and Bleeding Outcomes
- (2020) Catherine Y. S. Cheung et al. ANNALS OF PHARMACOTHERAPY
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Direct oral anticoagulants and advanced liver disease: A systematic review and meta‐analysis
- (2020) Danilo Menichelli et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Anticoagulation in patients with advanced liver disease: an open issue
- (2020) Francesco Violi et al. Internal and Emergency Medicine
- Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
- (2020) Marco Valerio Mariani et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Predicting Who Will Experience Cerebral Hemorrhage When Anticoagulated
- (2020) James F. Meschia MAYO CLINIC PROCEEDINGS
- Direct Oral Anticoagulant Concentrations in Obese and High Body Weight Patients: A Cohort Study
- (2020) Anne Céline Martin et al. THROMBOSIS AND HAEMOSTASIS
- Direct Oral Anticoagulant Dosing in Extremes of Body Weight: Time to Revisit the Guidelines?
- (2020) Arjun K. Pandey et al. THROMBOSIS AND HAEMOSTASIS
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial
- (2020) Giuseppe Boriani et al. THROMBOSIS AND HAEMOSTASIS
- Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
- (2020) Maxim Grymonprez et al. Frontiers in Pharmacology
- Patients with diabetes mellitus and atrial fibrillation treated with NOACs: Meta-analysis of 8 outcomes in 58, 634 patients across 4 randomized controlled trials
- (2020) Anna Plitt et al. European Heart Journal-Cardiovascular Pharmacotherapy
- American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
- (2020) Thomas L. Ortel et al. Blood Advances
- Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial
- (2020) Chris Wilkinson et al. BMC Medicine
- Concomitant diabetes with atrial fibrillation and anticoagulation management considerations
- (2020) Reinhold Kreutz et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis
- (2020) Benilde Cosmi EXPERT OPINION ON PHARMACOTHERAPY
- New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation
- (2020) Sergio Raposeiras Roubín et al. Journal of the American Heart Association
- Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population
- (2020) Jennifer D. Guo et al. THROMBOSIS RESEARCH
- Meta-analysis of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients >75 Years of Age
- (2019) Aaqib H. Malik et al. AMERICAN JOURNAL OF CARDIOLOGY
- Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project
- (2019) Antonio Di Carlo et al. EUROPACE
- Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism
- (2019) Michela Giustozzi et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Oral anticoagulation in patients with chronic kidney disease
- (2019) Konark Malhotra et al. NEUROLOGY
- Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
- (2019) Peter Brønnum Nielsen et al. STROKE
- Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight
- (2019) Stefan H. Hohnloser et al. CIRCULATION
- Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis
- (2019) Zhi-Chun Gu et al. Clinical Gastroenterology and Hepatology
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
- (2019) Stavros V Konstantinides et al. EUROPEAN HEART JOURNAL
- Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation
- (2019) Shankar Kumar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
- (2018) Meena P. Rao et al. AMERICAN JOURNAL OF MEDICINE
- Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
- (2018) Guowei Li et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism
- (2018) Menno V. Huisman et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis
- (2018) Ronpichai Chokesuwattanaskul et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
- (2018) Yana Vinogradova et al. BMJ-British Medical Journal
- Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
- (2018) Yana Vinogradova et al. BMJ-British Medical Journal
- Anticoagulation at the extremes of body weight: choices and dosing
- (2018) Georgia J. B. McCaughan et al. Expert Review of Hematology
- Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation
- (2018) Eri Toda Kato et al. AGEING RESEARCH REVIEWS
- Treatment of bleeding complications in patients on anticoagulant therapy
- (2018) Siavash Piran et al. BLOOD
- Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
- (2018) Giuseppe Boriani et al. EUROPEAN HEART JOURNAL
- Extended treatment of venous thromboembolism: a systematic review and network meta-analysis
- (2018) Kang-Ling Wang et al. HEART
- Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding
- (2018) Wayne A. Ray et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
- (2018) Xiaoyan Li et al. THROMBOSIS AND HAEMOSTASIS
- Does atrial fibrillation lead to cognitive decline and dementia?
- (2017) Hans-Christoph Diener EUROPEAN HEART JOURNAL
- Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the “Real World”
- (2017) Michał Mazurek et al. GASTROENTEROLOGY
- Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study
- (2017) Neena S. Abraham et al. GASTROENTEROLOGY
- Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis
- (2017) Giuseppe Andò et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation
- (2017) George Ntaios et al. STROKE
- Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
- (2017) Ka-Shing Cheung et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
- (2017) José A López-López et al. BMJ-British Medical Journal
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
- (2017) José A López-López et al. BMJ-British Medical Journal
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
- (2016) Peter A. Noseworthy et al. CHEST
- Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
- (2016) Frederikus A. Klok et al. EUROPEAN RESPIRATORY JOURNAL
- Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling
- (2016) Jan Steffel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
- (2016) Ziad Hijazi et al. LANCET
- What to do after the bleed: resuming anticoagulation after major bleeding
- (2016) D. M. Witt Hematology-American Society of Hematology Education Program
- How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
- (2015) Jordan K. Schaefer et al. ANNALS OF HEMATOLOGY
- Matching the NOAC to the Patient
- (2015) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
- (2015) J. Claude Hemphill et al. STROKE
- Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding
- (2015) Chatree Chai-Adisaksopha et al. THROMBOSIS AND HAEMOSTASIS
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- (2015) N. S. Abraham et al. BMJ-British Medical Journal
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- (2015) N. S. Abraham et al. BMJ-British Medical Journal
- Anticoagulant-related gastrointestinal bleeding—could this facilitate early detection of benign or malignant gastrointestinal lesions?
- (2014) Andreas Clemens et al. ANNALS OF MEDICINE
- European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
- (2014) Thorsten Steiner et al. International Journal of Stroke
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
- (2013) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy for VTE Disease
- (2012) Clive Kearon et al. CHEST
- Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
- (2012) Antonio L. Dans et al. CIRCULATION
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
- (2011) Margaret C. Fang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry
- (2008) Nuria Ruíz-Giménez et al. THROMBOSIS AND HAEMOSTASIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started